Integra Now Offers New High-Volume Pipettes
Pharmaceutical Technology's In the Lab eNewsletter
The company has launched new high volume eight- and 12-channel pipettes, offering a capacity of 1250 µL per channel.
Integra Biosciences has expanded its comprehensive collection of pipettes with the launch of two new EVOLVE manual pipettes. The company now offers high-volume eight- and 12-channel options, offering a capacity of 1250 µL per channel, the company announced in a March 3, 2020 press release.
The EVOLVE pipette family now comprises an assortment of single-, eight-, 12-, and 16-channel manual pipettes, covering a volume range of 0.2 µL to 5000 µL, making them suitable for cell culture applications. The manually actuated plunger can generate significantly more force for aspirating and dispensing than an electronic pipette, which offers the advantage of vigorous mixing and breaking up of cell pellets. The new pipettes retain all the same beneficial features of the EVOLVE product line, including quick-set dials for volume setting and a lightweight ergonomic design for more comfortable and productive pipetting.
The new pipettes also use the company’s GripTip pipette tips, which include a range of specialty tips aimed at cellular applications, such as 1250 µL short tips-for more ergonomic pipetting-and wide bore tips, which help to eliminate cell shearing and aid pipetting of viscous solutions.
For higher throughput cell-based applications, the company also offers the VIAFLO 96/384-a compact and easy-to-use solution for 24-, 96-, and 384-channel pipetting-which enables filling, mixing, or seeding of an entire plate in one dispense.
Source: Integra
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
